A multilevel intervention to support weight loss among individuals with prediabetes in primary care settings
Project Number5K23DK123416-05
Contact PI/Project LeaderGRIAUZDE, DINA HAFEZ
Awardee OrganizationUNIVERSITY OF MICHIGAN AT ANN ARBOR
Description
Abstract Text
Modified Project Summary/Abstract Section
Candidate: Dina H. Griauzde, MD, MSc is a general internist and early career health services researcher focused on preventing type 2 diabetes (T2DM). Dr. Griauzde’s long-term career objective is to become an independent physician-scientist leading the development and evaluation of tailored, multilevel interventions for T2DM prevention that can be scaled and sustained within diverse practice settings.
Research Context: Weight loss is the key driver of T2DM risk reduction. Patients prefer and benefit from preference-sensitive weight loss treatment plans, which may require adaptations over time to optimize outcomes. While primary care providers and practices theoretically play a central role in supporting patients’ weight loss, they lack coordinated, effective, and sustainable strategies to personalize and adapt treatment plans to help more individuals with prediabetes achieve clinically significant weight loss. Accordingly, obesity remains poorly managed in primary care settings.
Specific Aims: The overarching aim of this proposal is to use implementation science (i.e., the study of provider behavior within the context of organizational constraints) to develop, implement, and evaluate a novel multilevel intervention to support personalized and adaptable weight loss treatment plans in primary care settings. Multilevel interventions target at least two levels of influence (e.g., providers, health system) and are a promising strategy to promote significant and sustained changes in clinical practice. Intervention components will be selected to address key determinants of successfully supporting patients’ weight loss.
Research Plan: Dr. Griauzde will use a theory-based implementation science checklist to guide semi-structured interviews with patients, providers, practice staff, and system leaders to identify determinants of successfully supporting patients’ weight loss (Aim 1). She will then link key determinants to evidence- and theory-based implementation strategies to develop of a novel, multilevel intervention, consisting of (1) personalized weight loss plans; (2) remote weight monitoring; and (3) proactive outreach by primary care teams and/or automated tools to provide support and/or adapt treatment plans to optimize weight loss (Aim 2). She will evaluate the intervention using a match cohort analysis (Aim 3). These data will inform a future multisite study of the refined intervention.
Career Development Plan: Dr. Griauzde will develop expertise in (1) implementation science; (2) multilevel intervention design; and (3) mixed methods design and evaluation of clinical programs. Dr. Griauzde’s training will be supported by experienced, interdisciplinary mentors; advanced didactic coursework; and participation in research and career development meetings and seminars within an ideal training environment. This award will enable Dr. Griauzde to become an independent investigator and national leader in developing, testing, and implementing multilevel interventions for the prevention of T2DM and other obesity-related chronic conditions.
Public Health Relevance Statement
Modified Public Health Relevance Section
Modest weight loss (>5% body weight) is the most effective strategy to help individuals with prediabetes prevent or delay type 2 diabetes mellitus. Most individuals with prediabetes, however, do not engage in evidence-based Diabetes Prevention Programs for weight loss, and healthcare systems currently lack effective, coordinated, and patient-centered strategies to successfully support patients’ weight loss with other evidence-based resources (e.g. behavioral change programs, pharmacotherapy). This proposal aims to develop and test an innovative, multilevel primary care-based intervention to support weight loss among adults with prediabetes through (1) personalized weight loss plans; (2) remote weight monitoring using home-based digital scales; and (3) proactive outreach to address barriers and/or adapt plans if target weight loss is not achieved.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AddressAdherenceAdultAwardBehaviorBehavioralBody WeightBody Weight ChangesBody Weight decreasedCaringChronicChronic DiseaseClinicClinicalClinical effectivenessCohort AnalysisCommunitiesCounselingDataDevelopmentDevelopment PlansDiabetes preventionDietEffectiveness of InterventionsElectronic Health RecordEnhancement TechnologyEnvironmentEvaluationFaceFoundationsFutureGoalsGuidelinesHealth ServicesHealth systemHealthcare SystemsHomeIndividualInternistInterventionInterviewKilogramKnowledgeLeadershipLife StyleLinkMeasuresMentorsMethodsMonitorNon-Insulin-Dependent Diabetes MellitusObesityOutcomePatient MonitoringPatient-Centered CarePatientsPharmacotherapyPhysical activityPhysiciansPlayPrediabetes syndromePreventionPrevention strategyPrimary CareProviderResearchResearch PersonnelResourcesRiskRisk ReductionRoleScientistSiteStructureSystemTestingTimeTrainingVisitWeightWeight maintenance regimenWorkcareercareer developmentclinical encounterclinical implementationclinical practiceclinically significantdesigndiabetes prevention programdigitaleffectiveness/implementation hybridevidence baseexperiencefollow-uphybrid type 1 designimplementation scienceimplementation strategyimprovedinformantinnovationintervention refinementmeetingsmembernovelnovel strategiesobesity managementoutreachpatient orientedpilot testpractice settingpragmatic trialpreferencepreventprimary care practiceprimary care providerprimary care settingprimary care teamprimary outcomeprogramsprovider behaviorpublic health relevanceresearch and developmentresearch clinical testingskillstheoriestherapy designtooltreatment planninguptakeweight loss interventionweight loss program
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
847
DUNS Number
073133571
UEI
GNJ7BBP73WE9
Project Start Date
01-August-2020
Project End Date
30-June-2025
Budget Start Date
01-June-2024
Budget End Date
30-June-2025
Project Funding Information for 2024
Total Funding
$190,301
Direct Costs
$176,205
Indirect Costs
$14,096
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Diabetes and Digestive and Kidney Diseases
$190,301
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5K23DK123416-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5K23DK123416-05
Patents
No Patents information available for 5K23DK123416-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5K23DK123416-05
Clinical Studies
No Clinical Studies information available for 5K23DK123416-05
News and More
Related News Releases
No news release information available for 5K23DK123416-05
History
No Historical information available for 5K23DK123416-05
Similar Projects
No Similar Projects information available for 5K23DK123416-05